Last Night Laidlaw Published Positive Comments on Aldeyra Therapeutics (ALDX), PT $11, 'a great buying opportunity given the very limited downside and much greater upside'
Tweet Send to a Friend
Laidlaw analyst Yale Jen reiterated a Buy rating and $11.00 price target on Aldeyra Therapeutics (NASDAQ: ALDX)The analyst comments "This ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
